NYSE
BBBY
Last Price
US $5.15
KEY FIGURES
MKT CAP
$383.6M
EPS
TTM
$-0.89
PEG
TTM
-
P/E
TTM
N/M
P/S
TTM
0.34x
YIELD
0.00%
GROWTH
Revenue Y/Y
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Bed Bath & Beyond Inc. cash flow to debt ratio of -256.90% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial stability - Healthy cash flow growth.
Bed Bath & Beyond Inc.'s free cash flow has increased -59.15% from $-194.66M last year to $-79.51M, signaling increasing performance
Financial stability - Healthy debt to equity ratio.
Bed Bath & Beyond Inc.'s debt to equity ratio is 0.11, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial stability - Healthy debt to equity ratio development.
Bed Bath & Beyond Inc.'s debt has decreased relative to shareholder equity from 0.20 last year to 0.11 today, signaling strengthened financials
Financial risk - Net debt/EBITDA.
Bed Bath & Beyond Inc. has negative EBITDA, making leverage ratio unreliable
Financial stability - ICR.
Bed Bath & Beyond Inc. earns at least as much interest as it pays. Interest obligations are fully covered.
Financial stability - Profit margin growth.
Bed Bath & Beyond Inc.'s profit margin has increased (-68.94%) in the last year from -18.55% to -5.76%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
Bed Bath & Beyond Inc.'s short-term assets of $240.12M exceed its short-term liabilities of $192.15M
Decreasing performance - ROA.
Bed Bath & Beyond Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Bed Bath & Beyond Inc.'s return on equity of -32.45%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
Bed Bath & Beyond Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Decreasing performance - Earnings stability.
Bed Bath & Beyond Inc. had positive net income in only 1.00 out of 5 years, indicating unstable earnings
Decreasing performance - Free cash flow.
Bed Bath & Beyond Inc. has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
Bed Bath & Beyond Inc. has negative free cash flow, indicating cash burn
Increasing performance - Healthy earnings growth.
Bed Bath & Beyond Inc.'s yearly earnings has increased -67.30% since last year from $-258.80M to $-84.62M, signaling increasing performance
Decreasing performance - Healthy revenue growth.
Bed Bath & Beyond Inc.'s yearly revenue has decreased -25.12% since last year from $1.39G to $1.04G, signaling decreasing performance
Decreasing performance - ROIC.
ROIC -24.21% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Decreasing performance - 3-year revenue CAGR.
Bed Bath & Beyond Inc.'s 3-year revenue CAGR of -18.50% is negative, indicating declining revenue over the past 3 years
Decreasing performance - Revenue consistency.
Bed Bath & Beyond Inc. had revenue growth in only 1.00 out of 5 years, indicating inconsistent revenue performance
Decreasing performance - ROE consistency.
Bed Bath & Beyond Inc. had positive ROE in only 1.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
Bed Bath & Beyond Inc. has insufficient data to evaluate this check.
Overvalued - Earnings yield.
Bed Bath & Beyond Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
Bed Bath & Beyond Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Overvalued - EV/EBITDA.
Bed Bath & Beyond Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable
Overvalued - PEG ratio value.
Bed Bath & Beyond Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Undervalued - P/B ratio.
Bed Bath & Beyond Inc. has a price-to-book ratio of 1.76x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Bed Bath & Beyond Inc. has a price-to-sales ratio of 0.34x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-32.45%
Return on equity
ROIC: -24.21%
Valuation History
-5.5X
Price to Earnings
EV/EBITDA: -7.5X
Cash flow
Profit margin
-19.55%
(FY vs FY)
EBITDA Y/Y
-
(FY vs FY)
Cash flow Y/Y
5.39%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $5.15
—
Default assumptions
EBITDA Multiple
Fair Value
Market $5.15
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.